Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Dare Bioscience Inc DARE

Healthcare
Dare Bioscience, Inc. is a biopharmaceutical company committed to advancing products for women's health. XACIATO, the Company's United States Food and Drug Administration (FDA)-approved product, vaginal gel 2%, a lincosamide antibacterial indicated for the treatment of bacterial vaginosis in female patients 12 years of age and older, which is under a global license agreement with Organon. Its... see more

Opinion & Analysis (NDAQ:DARE)

    US Biopharma to Launch Phase 3 Trial in Bacterial Vaginosis

    Streetwise Reports May 21, 2020

    Biotech Announces Deal with Bayer on Non-Hormonal Contraception

    Streetwise Reports January 16, 2020

    Biopharma 'Keeps Executing and Securing Milestones'

    Streetwise Reports December 19, 2019

    Biotech Firm ''Creating Innovative Solutions' for Female Health

    Streetwise Reports July 24, 2019

    Biotech Announces Preclinical Data on its Intravaginal Rings at Meeting

    Streetwise Reports November 13, 2018

    Biopharma's Positive FDA Meeting Outlines Path Forward for Trial

    Streetwise Reports September 12, 2018

    Coverage Initiated on Company with a Pipeline of Women's Health Products

    Streetwise Reports August 22, 2018

    Coverage Initiated on Developer of Women's Reproductive Health Products

    Streetwise Reports May 30, 2018